{"schema_version":"secwatch.filing_event.v1","accession":"0001420720-23-000072","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2023-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.013910+00:00","generated_at":"2026-06-07T07:17:12.034927+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"iBio amends credit agreement: maturity extended to March 29, 2024, rate cut to 4.5%","bullets":["Maturity extended from Dec 31, 2023 to earlier of March 29, 2024 or acceleration of term loan.","Interest rate reduced from 5.25% to 4.5%; payment-in-kind increased from 3% to 4.5%.","Borrower must maintain minimum $900K reserve; best efforts to sell cGMP manufacturing facility before maturity.","Woodforest fee increased by $10,000 to $155,000, payable at sale closing or maturity date.","Amendment provides additional flexibility to complete divestiture of CDMO business and advance AI immunotherapy platform."],"urls":{"canonical":"https://secwatch.observer/filing/0001420720-23-000072","json":"https://secwatch.observer/filing/0001420720-23-000072.json","markdown":"https://secwatch.observer/filing/0001420720-23-000072.md","text":"https://secwatch.observer/filing/0001420720-23-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000142072023000072/0001420720-23-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000142072023000072/ibio-20231222x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T07:17:12.034927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9b00cfd9b79ebdcf9775476783ad38737992bf78","claim":"iBio, Inc. amended Eighth Amendment with Woodforest National Bank (effective 2023-12-22).","evidence_excerpt":"On December 22, 2023, iBio CDMO LLC (“Borrower”), a wholly owned subsidiary of iBio, Inc. (the “Company”) and Woodforest National Bank (“Woodforest”) entered into the Eighth Amendment (the “Eight Amendment”) to the Credit Agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1420720/000142072023000072/0001420720-23-000072-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Woodforest National Bank"},{"label":"Effective","value":"2023-12-22"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}